RT Journal Article
SR Electronic
T1 A comparative study of infection and mortality in COVID-19 across countries: A scaling analysis
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.10.13.20212175
DO 10.1101/2020.10.13.20212175
A1 Ranjan Das
A1 Akmal Hossain
A1 Sayak Mandal
A1 Debasmita Pariari
A1 Rohit Kumar Rohj
A1 Swapnil Shukla
A1 Rahul Mahavir Varma
A1 D. D. Sarma
YR 2020
UL http://medrxiv.org/content/early/2020/10/14/2020.10.13.20212175.abstract
AB Analysing infection and mortality data for COVID-19 as a function of days for 54 countries across all continents, we show that there is a simple scaling behaviour connecting these two quantities for any given nation when the data is segmented over few ranges of dates covering the most rapid spread of the pandemic and the recovery, wherever achieved. This scaling is described by two parameters, one representing a shift along the time axis and the other is a normalisation factor, providing a reliable definition of the mortality rate for each country in a given period. The number of segments for any country required in our analyses turns out to be surprisingly few with as many as 16 out of 54 countries being described by a single segment and no country requiring more than three segments. Estimates of the shift and mortality for these 54 countries in different periods show large spreads ranging over 0-16 days and 0.45-19.96%, respectively. Shift and mortality are found to be inversely correlated. Analyses of number of tests carried out for detecting COVID-19 and the number of infections detected due to such tests suggest that an effective way to increase the shift, and therefore, decrease mortality, is to increase number of tests per infection detected. This points to the need of a dynamic management of testing that should accelerate with the rise of the pandemic; it also suggests a basis for adjusting variations in the testing patterns in different geographical locations within a given country.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors thank Science and Engineering Research Board and the Department of Science and Technology, Government of India as well as Jamsetji Tata Trust for their continued support.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The article focuses on the statistical analysis of the progression of the COVID-19 pandemic and the correlation between the infection and mortality with the help of simple scaling behavior. In view of that, the given manuscript does not seek any IRB approval.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll the data related to this study are available from the corresponding author upon reasonable request.PeriodThe total period investigated for any given countryMboundLowest bound on the %mortality per detected case as on the last date of analysis, defined as the total number of death divided by the total number of cases on the last date of the analysis periodNsegNumber of segments required for the analysis of this countryStart dateThe first date included in the analysis of that segmentEnd dateThe last date included in the analysis of that segmentSShift required for the best fitFFactor required for the best fitMMortality rate in %, defined as (100/F)NinfectionsTotal number of infections in the specified period between the start and end datesNtestsTotal number of tests in the specified period between the start and end dates%Positive casesNumber of infections detected per hundred tests carried out in the specified period between the start and end dates